Extended release triamcinolone better for knee OA pain


An extended-release formulation of triamcinolone acetonide gives a clinically relevant improvement in pain relief in patients with knee OA compared to the immediate release formulation, a phase II trial finds. The double blind dose ranging study randomised 228 patients with moderate to severe knee OA to a single intra-articular injection of 10mg, 40mg, or 60 ...


Already a member? Login to keep reading


OR
© 2017 the limbic